Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.
The shot — for now called mRNA-1083 — “has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial,” Moderna said.
The dual-purpose shot, won’t be okayed in time for this years’ flu season.
